Steve Anderson

Want to write for 麻豆社 too? Apply to join 麻豆社 Leadership network.

More From Steve Anderson

Business News

Time to Join Sorrento Therapeutics on its Next Leg Up

We've heard from Sorrento Therapeutics (NASDAQ:SRNE) before, and usually, things are looking good for the biotechnology industry firm. While it's never been a big player鈥攕hare prices haven't broken the $15 price point in the last five years

More Authors You Might Like